BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32743044)

  • 1. Features and clinical impact of extra-cardiac lesions with
    Higashi H; Inaba S; Iio C; Inoue K; Ogimoto A; Miyagawa M; Mochizuki T; Ikeda S; Yamaguchi O
    Int J Cardiol Heart Vasc; 2020 Oct; 30():100587. PubMed ID: 32743044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
    Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
    Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
    J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis.
    Manabe O; Yoshinaga K; Ohira H; Sato T; Tsujino I; Yamada A; Oyama-Manabe N; Masuda A; Magota K; Nishimura M; Tamaki N
    Ann Nucl Med; 2014 Aug; 28(7):656-63. PubMed ID: 24889126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic yield of whole-body
    Saleh JK; Barkmeier D; Frey KA; Davenport MS
    J Nucl Cardiol; 2023 Oct; 30(5):1773-1781. PubMed ID: 36829085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Utility of Whole Body
    Giudicatti L; Marangou J; Nolan D; Dembo L; Baumwol J; Dwivedi G
    Heart Lung Circ; 2020 Jan; 29(1):e1-e6. PubMed ID: 31501049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18-FDG-PET in a patient cohort suspected for cardiac sarcoidosis: Right ventricular uptake is associated with pathological uptake in mediastinal lymph nodes.
    Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K; Sipilä K
    J Nucl Cardiol; 2020 Feb; 27(1):109-117. PubMed ID: 29721764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body
    Juneau D; Nery P; Russo J; de Kemp RA; Leung E; Beanlands RSB; Birnie DH
    Int J Cardiol; 2018 Feb; 253():189-193. PubMed ID: 29306462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated cardiac sarcoidosis diagnosed by electroanatomic voltage mapping-guided endomyocardial biopsy combined with magnetic resonance imaging and positron emission tomography.
    Kawakatsu N; Suzuki A; Serizawa N; Suzuki T; Ejima K; Shiga T; Fukushima K; Momose M; Uto K; Shoda M; Hagiwara N
    J Cardiol Cases; 2016 Oct; 14(4):107-110. PubMed ID: 30524562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
    Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
    Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
    Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
    Manabe O; Ohira H; Yoshinaga K; Sato T; Klaipetch A; Oyama-Manabe N; Ito YM; Tsujino I; Nishimura M; Tamaki N
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1558-66. PubMed ID: 23715906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of
    Norikane T; Yamamoto Y; Maeda Y; Noma T; Dobashi H; Nishiyama Y
    EJNMMI Res; 2017 Aug; 7(1):69. PubMed ID: 28853043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET-Driven, Voltage-Guided Atrial Endomyocardial Biopsy Clinches the Diagnosis of Cardiac Sarcoidosis.
    Flautt T; Lador A; Da-Wariboko A; Schwartz M; Valderrábano M
    JACC Case Rep; 2021 Nov; 3(16):1764-1768. PubMed ID: 34825206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis.
    Ishiyama M; Soine LA; Vesselle HJ
    EJNMMI Res; 2017 Aug; 7(1):67. PubMed ID: 28822108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac sarcoidosis: the role of cardiac MRI and
    Al Hayja MA; Vinjamuri S
    Br J Cardiol; 2023; 30(1):7. PubMed ID: 37705835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
    Ohira H; Tsujino I; Ishimaru S; Oyama N; Takei T; Tsukamoto E; Miura M; Sakaue S; Tamaki N; Nishimura M
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):933-41. PubMed ID: 18084757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.
    Braun JJ; Kessler R; Constantinesco A; Imperiale A
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1537-43. PubMed ID: 18418595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.